Chromisthera

1 known investors

Chromis Thera is a pharmaceutical company developing drugs to treat viral diseases, including a Favipiravir-based treatment for COVID-19 and therapies targeting hepatitis B virus (HBV). Its focus areas include antiviral drug development in oncology-related indications such as HBV, a leading cause of cancer-related illness and death.